In this video, Ian Bouligny, MD, discusses his team’s research that aimed to determine the impact of secondary-type mutations in patients who were newly diagnosed with acute myeloid leukemia and treated...
A 67-year-old man presented to the hospital with progressive shortness of breath for 4 days, which worsened with exertion and was relieved by rest. He also noted one episode of dark vomitus and one episode...
Your patient is a 38-year-old man who consumes primarily sugar-sweetened drinks with his meals. Along with weight gain, he is concerned about other problems these drinks may cause and asks what are the...
Your patient is a 38-year-old man who consumes primarily sugar-sweetened drinks with his meals. Along with weight gain, he is concerned about other problems these drinks may cause and asks what are the...
Consultant360’s Photoclinic Challenge is an interactive quiz based on an image featured in a Photoclinic article. View the slideshow for a brief overview of the case, patient history, and a key hint.
Acute myeloid leukemia is one of the most common types of leukemia in adults, but what is the incidence of this type of leukemia among overall cases of cancer? Find out with this pop quiz.
In this video, Ian Bouligny, MD, discusses his team’s research that aimed to determine the impact of secondary-type mutations in patients who were newly diagnosed with acute myeloid leukemia and treated...
In this video, Kendall Diebold, DNP, FNP-C, speaks about her team’s research titled “Outcomes of 3- Versus 5-Day Administration Schedule of Consolidation Cytarabine in Adults with Acute Myeloid Leukemia,”...
This video highlights various methods our oncologists use to counsel their patients to better understand their breast cancer diagnosis by discussing the associated risk factors, the heterogenous nature of...
In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...
In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
